Growth Hormone Peptides and Shoulder Recovery

Growth hormone–promoting peptides are often marketed for recovery, muscle preservation, fat loss, sleep, energy, and tissue healing.

Patients recovering from shoulder injury or surgery may ask whether these peptides can improve strength, healing, or recovery speed.

Common growth hormone-related peptides

Commonly discussed compounds include:

• CJC-1295
• Ipamorelin
• MK-677 / ibutamoren
• Other growth hormone secretagogues

These compounds are discussed because growth hormone and IGF-1 signaling are involved in muscle, bone, collagen, metabolism, and recovery biology.

Why this matters in shoulder surgery

Shoulder recovery depends on muscle function, tendon quality, bone quality, inflammation control, and rehabilitation.

Theoretically, growth hormone signaling could be relevant to:

• Muscle preservation
• Bone healing
• Tendon and collagen biology
• Recovery after injury
• Age-related muscle loss

However, biologic relevance does not automatically mean a treatment improves outcomes after shoulder surgery.

Safety concerns

Growth hormone–promoting compounds may have important risks, especially in older patients or patients with metabolic or cardiovascular disease.

• Fluid retention
• Swelling
• Insulin resistance
• Blood sugar changes
• Possible cardiovascular concerns
• Uncertain long-term safety
• Variable quality in compounded or nonregulated products

These risks matter because many shoulder surgery patients are older and may have diabetes, cardiovascular disease, or other medical conditions.

What this means for patients

Growth hormone peptides are not established orthopedic recovery treatments after shoulder surgery.

They may be biologically interesting, but they require caution, medical oversight, and realistic expectations.

For shoulder patients, the priority remains safe rehabilitation, protein intake, sleep, metabolic health, and procedure-specific recovery rather than unproven hormone manipulation.